Our Biomedical Future: "Brains on a Chip," Tissue Engineering, Gene Therapy

In her five-year trend forecast at the MIT Enterprise Forum, consultant Valerie Pajak focused on the frontiers of biomedicine, everything from combating disease at the genetic level to the financial benefits of a healthy population. "Prevention is not everything," she says. "The pursuit of a cure is still important."

Pajak is a management consultant with bioStrategies Group, a Chicago consulting firm specialing in new pharmaceutical and biologic research and analysis.

She was a co-founder of a biotech company in Pittsburgh, PA that commercialized proprietary peptide biomarkers for the early detection of disease and disease management. Early in her career Pajak was a bench scientist in R&D at big pharma and served in various marketing roles in biotech and other industries. She holds a BA in biomedical illustration and neuroscience from the University of Pittsburgh and an MBA from Carnegie Mellon University.

The 7th Annual Innovation & Technology Forecast: 2007-2011 featured a panel of experts as they discuss the future of IT, communications, smart buildings, nanotech, biotech and biomedicine. It was hosted by nanotech expert and SitterCity.com VP Dan Ratner. The event was held January 16, 2007 at the office of law firm Drinker Biddle Gardner Carton LLP.

MIT Enterprise Forum

Part 1 of our coverage of the innovation and technology forecast featured David Findling from Motorola.. Part 2 featured Geoffrey Kasselman of Op2mize and can be found here.

Article_tool_feedback
Article_tool_email
Site Development by The Killswitch Collective
Skyscraper